REGULATION OF B-CELL APOPTOSIS BY BCL-2 AND BCL-X-L AND ITS ROLE IN THE DEVELOPMENT OF AUTOIMMUNE-DISEASES (REVIEW)

Citation
M. Lopezhoyos et al., REGULATION OF B-CELL APOPTOSIS BY BCL-2 AND BCL-X-L AND ITS ROLE IN THE DEVELOPMENT OF AUTOIMMUNE-DISEASES (REVIEW), INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1(2), 1998, pp. 475-483
Citations number
116
Categorie Soggetti
Medicine, Research & Experimental
ISSN journal
11073756
Volume
1
Issue
2
Year of publication
1998
Pages
475 - 483
Database
ISI
SICI code
1107-3756(1998)1:2<475:ROBABB>2.0.ZU;2-4
Abstract
Cell death is a common event during B cell development. The demise of developing B cells is a regulated process that serves to select cell p opulations bearing functional receptors and to remove cells that are n o longer needed or potentially autoreactive. Bcl-2 and Bcl-X-L, two me mbers of the bcl-2 gene family of programmed cell death regulators wit h anti-apoptotic activity, are expressed in a highly regulated pattern during B cell maturation. Overexpression of Bcl-2 in developing B cel ls of transgenic mice, in the presence of T cell dependent costimulato ry signals, results in the generation of a modified B cell repertoire and in the production of pathogenic autoantibodies. While disregulatio n of programmed cell death in B cells may cause autoimmune manifestati ons in mice, the involvement of such alterations in the pathogenesis o f autoimmune diseases in humans merits further investigation.